期刊
MOLECULAR BRAIN RESEARCH
卷 102, 期 1-2, 页码 118-128出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0169-328X(02)00216-4
关键词
cAMP; striatum; Huntingtin; SKF-38393
资金
- NINDS NIH HHS [NS38106, NS10800] Funding Source: Medline
The diminished expression of D-1 and D-2 dopamine receptors is a well-documented hallmark of Huntington's disease (HD), but relatively little is known about how these changes in receptor populations affect the dopaminergic responses of striatal neurons. Using transgenic mice expressing an N-terminal portion of mutant huntingtin (R6/2 mice). we have examined immediate early gene (IEG) expression as an index of dopaminergic signal transduction. c-fos, jun B, zif268. and N10 mRNA levels and expression patterns were analyzed using quantitative in situ hybridization histochemistry following intraperitoneal administration of selective D-1 and D-2 family pharmacological agents (SKF-82958 and eticlopride). Basal IEG levels were generally lower in the dorsal subregion of R6/2 striata relative to wild-type control striata at 10-11 weeks of age, a finding in accord with previously reported decreases in D-1 and adenosine A(2A) receptors, D-antagonist-stimulated IEG expression was significantly reduced in the striata of transgenic animals, In contrast, D-1-agonist-induced striatal R6/2 IEG mRNA levels were either equivalent or significantly enhanced relative to control levels, an unexpected result given the reduced level of D, receptors in R6/2 animals. Understanding the functional bases for these effects may further elucidate the complex pathophysiology of Huntington's disease. (C) 2002 Elsevier Science B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据